Browsing by Author "Sharma, U"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Content validity of the newly developed risk assessment tool for religious mass gathering events in Indian settings (Mass Gathering Risk Assessment Tool-MGRAT).(J Family Med Prim Care, 2019-07) Sharma, U; Desikachari, BR; Sarma, SBackground: Risk assessment (RA) for mass gathering events is crucial to identify potential health hazards. It aids in planning and response activities specific to the event but is often overlooked by the event organizers. This paper reports the content validity process of a newly developed tool called Mass Gathering Risk Assessment Tool (MGRAT), which intends to assess the risks associated with religious mass gathering events in Indian settings. Methods: Qualitative approach was followed to identify the risks associated with mass gathering events and to identify the domains and items to be included in the RA tool. The draft tool was shared with six experts who were selected by the convenient method; selected experts were requested to assess the tool and give their comments about the domains, items, relevant responses, and overall presentation of the tool using content validity questionnaire. Content validity index and Fleiss kappa statistics were calculated to assess the agreement between multiple raters. Results: Agreement proportion expressed as scale-level content validity index (S-CVI) calculated by the averaging method is 0.92. S-CVI; calculated by universal agreement is 0.78. Fleiss kappa statistics to measure the agreement between multiple experts after adjusting the component of the chance agreement is 0.522 (95% CI: 0.417, 0.628, P value: 0.001). Conclusion: MGRAT is a valid tool, which has an appropriate level of content validity. As the number of raters increases, there will be difficulty in achieving consensus among all the items, which is the reason for lower Content Validity Index/Universal Average (CVI/UA) when compared with Content Validity Index/Average (CVI/Ave). Fleiss kappa statistics also indicated moderate agreement among the raters beyond the chance agreement, which also supports the appropriate content validity of MGRAT.Item Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015(LANCET) Vos, T; Allen, C; Arora, M; Barber, RM; Bhutta, ZA; Brown, A; Carter, A; Casey, DC; Charlson, FJ; Chen, AZ; Coggeshall, M; Cornaby, L; Dandona, L; Dicker, DJ; Dilegge, T; Erskine, HE; Ferrari, AJ; Fitzmaurice, C; Fleming, T; Forouzanfar, MH; Fullman, N; Gething, PW; Goldberg, EM; Graetz, N; Haagsma, JA; Johnson, CO; Kassebaum, NJ; Kawashima, T; Kemmer, L; Khalil, IA; Kinfu, Y; Kyu, HH; Leung, JN; Liang, XF; Lim, SS; Lopez, AD; Lozano, R; Marczak, L; Mensah, GA; Mokdad, AH; Naghavi, M; Nguyen, G; Nsoesie, E; Olsen, H; Pigott, DM; Pinho, C; Rankin, Z; Reinig, N; Salomon, JA; Sandar, L; Smith, A; Stanaway, J; Steiner, C; Teeple, S; Thomas, BA; Troeger, C; Wagner, JA; Wang, HD; Wanga, V; Whiteford, HA; Zoeckler, L; Abajobir, AA; Abate, KH; Abbafati, C; Abbas, KM; Abd-Allah, F; Abraham, B; Abubakar, I; Abu-Raddad, LJ; Abu-Rmeileh, NME; Ackerman, IN; Adebiyi, AO; Ademi, Z; Adou, AK; Afanvi, KA; Agardh, EE; Agarwal, A; Kiadaliri, AA; Ahmadieh, H; Ajala, ON; Akinyemi, RO; Akseer, N; Al-Aly, Z; Alam, K; Alam, NKM; Aldhahri, SF; Alegretti, MA; Alemu, ZA; Alexander, LT; Alhabib, S; Ali, R; Alkerwi, A; Alla, F; Allebeck, P; Al-Raddadi, R; Alsharif, U; Altirkawi, KA; Alvis-Guzman, N; Amare, AT; Amberbir, A; Amini, H; Ammar, W; Amrock, SM; Andersen, HH; Anderson, GM; Anderson, B; Antonio, CAT; Aregay, AF; Arnlov, J; Al Artaman; Asayesh, H; Assadi, R; Atique, S; Avokpaho, EFGA; Awasthi, A; Quintanilla, BPA; Azzopardi, P; Bacha, U; Badawi, A; Balakrishnan, K; Banerjee, A; Barac, A; Barker-Collo, SL; Barnighausen, T; Barregard, L; Barrero, LH; Basu, A; Bazargan-Hejazi, S; Bell, B; Bell, ML; Bennett, DA; Bensenor, IM; Benzian, H; Berhane, A; Bernabe, E; Betsu, BD; Beyene, AS; Bhala, N; Bhatt, S; Biadgilign, S; Bienhofff, K; Bikbov, B; Biryukov, S; Bisanzio, D; Bjertness, E; Blore, J; Borschmann, R; Boufous, S; Brainin, M; Brazinova, A; Breitborde, NJK; Brown, J; Buchbinder, R; Buckle, GC; Butt, ZA; Calabria, B; Campos-Nonato, IR; Campuzano, JC; Carabin, H; Cardenas, R; Carpenter, DO; Carrero, JJ; Castaneda-Orjuela, CA; Rivas, JC; Catala-Lopez, F; Chang, JC; Chiang, PPC; Chibueze, CE; Chisumpa, VH; Choi, JYJ; Chowdhury, R; Christensen, H; Christopher, DJ; Ciobanu, LG; Cirillo, M; Coates, MM; Colquhoun, SM; Cooper, C; Cortinovis, M; Crump, JA; Damtew, SA; Dandona, R; Daoud, F; Dargan, PI; das Neves, J; Davey, G; Davis, AC; De Leo, D; Degenhardt, L; Del Gobbo, LC; Dellavalle, RP; Deribe, K; Deribew, A; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dhillon, PK; Diaz-Torne, C; Ding, EL; Driscoll, TR; Duan, LL; Dubey, M; Duncan, BB; Ebrahimi, H; Ellenbogen, RG; Elyazar, I; Endres, M; Endries, AY; Ermakov, SP; Eshrati, B; Estep, K; Farid, TA; Farinha, CSES; Faro, A; Farvid, MS; Farzadfar, F; Feigin, VL; Felson, DT; Fereshtehnejad, SM; Fernandes, JG; Fernandes, JC; Fischer, F; Fitchett, JRA; Foreman, K; Fowkes, GR; Fox, J; Franklin, RC; Friedman, J; Frostad, J; Furst, T; Futran, ND; Gabbe, B; Ganguly, P; Gankpe, FG; Gebre, T; Gebrehiwot, TT; Gebremedhin, AT; Geleijnse, JM; Gessner, BD; Gibney, KB; Ginawi, IAM; Giref, AZ; Giroud, M; Gishu, MD; Glaser, E; Godwin, WW; Gomez-Dantes, H; Gona, P; Goodridge, A; Gopalani, SV; Gotay, CC; Goto, A; Gouda, HN; Grainger, R; Greaves, F; Guillemin, F; Guo, YM; Gupta, R; Gupta, R; Gupta, V; Gutierrez, RA; Haile, D; Hailu, AD; Hailu, GB; Halasa, YA; Hamadeh, RR; Hamidi, S; Hammami, M; Hancock, J; Handal, AJ; Hankey, GJ; Hao, YT; Harb, HL; Harikrishnan, S; Haro, JM; Havmoeller, R; Hay, RJ; Heredia-Pi, IB; Heydarpour, P; Hoek, HW; Horino, M; Horita, N; Hosgood, HD; Hoy, DG; Htet, AS; Huang, H; Huang, JJ; Huynh, C; Iannarone, M; Iburg, KM; Innos, K; Inoue, M; Iyer, VJ; Jacobsen, KH; Jahanmehr, N; Jakovljevic, MB; Javanbakht, M; Jayatilleke, AU; Jee, SH; Jeemon, P; Jensen, PN; Jiang, Y; Jibat, T; Jimenez-Corona, A; Jin, Y; Jonas, JB; Kabir, Z; Kalkonde, Y; Kamal, R; Kan, HD; Karch, A; Karema, CK; Karimkhani, C; Kasaeian, A; Kaul, A; Kawakami, N; Karimkhani, C; Kasaeian, A; Kaul, A; Kawakami, N; Keiyoro, PN; Kemp, AH; Keren, A; Kesavachandran, CN; Khader, YS; Khaiff, AR; Khaiff, EA; Khang, YH; Khera, S; Khoja, TAM; Khubchandani, J; Kieling, C; Kim, P; Kim, CI; Kim, D; Kim, YJ; Kissoon, N; Knibbs, LD; Knudsen, AK; Kokubo, Y; Kolte, D; Kopec, JA; Kosen, S; Kotsakis, GA; Koul, PA; Koyanagi, A; Kravchenko, M; Defo, BK; Bicer, BK; Kudom, AA; Kuipers, EJ; Kumar, GA; Kutz, M; Kwan, GF; Lal, A; Lalloo, R; Lallukka, T; Lam, H; Lam, JO; Langan, SM; Larsson, A; Lavados, PM; Leasher, JL; Leigh, J; Leung, R; Levi, M; Li, YC; Li, YM; Liang, J; Liu, SW; Liu, Y; Lloyd, BK; Lo, WD; Logroscino, G; Looker, KJ; Lotufo, PA; Lunevicius, R; Lyons, RA; Mackay, MT; Abd El Razek, MM; Mahdavi, M; Majdan, M; Majeed, A; Malekzadeh, R; Marcenes, W; Margolis, DJ; Martinez-Raga, J; Masiye, F; Massano, J; McGarvey, ST; McGrath, JJ; McKee, M; McMahon, BJ; Meaney, PA; Mehari, A; Meija-Rodriguez, F; Mekonnen, AB; Melaku, YA; Memiah, P; Memish, ZA; Mendoza, W; Meretoja, A; Meretoja, TJ; Mhimbira, FA; Miller, TR; Mills, EJ; Mirarefin, M; Mitchell, PB; Mock, CN; Mohammadi, A; Mohammed, S; Monasta, L; Hernandez, JCM; Montico, M; Mooney, MD; Moradi-Lakeh, M; Morawska, L; Mueller, UO; Mullany, E; Mumford, JE; Murdoch, ME; Nachega, JB; Nagel, G; Naheed, A; Naldi, L; Nangia, V; Newton, JN; Ng, M; Ngalesoni, FN; Le Nguyen, Q; Nisar, MI; Pete, PMN; Nona, JM; Norheim, OF; Norman, RE; Norrving, B; Nunes, BP; Ogbo, FA; Oh, IH; Ohkubo, T; Olivares, PR; Olusanya, BO; Olusanya, JO; Ortiz, A; Osman, M; Ota, E; Mahesh, PA; Park, EK; Parsaeian, M; Passos, VMD; Caicedo, AJP; Patten, SB; Patton, GC; Pereira, DM; Perez-Padilla, R; Perico, N; Pesudovs, K; Petzold, M; Phillips, MR; Piel, FB; Pillay, JD; Pishgar, F; Plass, D; Platts-Mills, JA; Polinder, S; Pond, CD; Popova, S; Poulton, RG; Pourmalek, F; Prabhakaran, D; Prasad, NM; Qorbani, M; Rabiee, RHS; Radfar, A; Rafay, A; Rahimi, K; Rahimi-Movaghar, V; Rahman, M; Rahman, MHU; Rahman, SU; Rai, RK; Rajsic, S; Ram, U; Rao, P; Refaat, AH; Reitsma, MB; Remuzzi, G; Resnikofff, S; Reynolds, A; Ribeiro, AL; Blancas, MJR; Rolm, HS; Rojas-Rueda, D; Ronfani, L; Roshandel, G; Roth, GA; Rothenbacher, D; Roy, A; Sagar, R; Sahathevan, R; Sanabria, JR; Sanchez-Nino, MD; Santos, IS; Santos, JV; Sarmiento-Suarez, R; Sartorius, B; Satpathy, M; Savic, M; Sawhney, M; Schaub, MP; Schmidt, MI; Schneider, IJC; Schottker, B; Schwebel, DC; Scott, JG; Seedat, S; Sepanlou, SG; Servan-Mori, EE; Shackelford, KA; Shaheen, A; Shaikh, MA; Sharma, R; Sharma, U; Shen, JB; Shepard, DS; Sheth, KN; Shibuya, K; Shin, MJ; Shiri, R; Shiue, I; Shrime, MG; Sigfusdottir, ID; Silva, DAS; Silveira, DGA; Singh, A; Singh, JA; Singh, OP; Singh, PK; Sivonda, A; Skirbekk, V; Skogen, JC; Sligar, A; Silwa, K; Soljak, M; Soreide, K; Soriano, JB; Sposato, LA; Sreeramareddy, CT; Stathopoulou, V; Steel, N; Stein, DJ; Steiner, TJ; Steinke, S; Stovner, L; Stroumpoulis, K; Sunguya, BF; Sur, P; Swaminathan, S; Sykes, BL; Szoeke, CEI; Tabares-Seisdedos, R; Takala, JS; Landon, N; Tanne, D; Tavakkoli, M; Taye, B; Taylor, HR; Te Ao, BJ; Tedla, BA; Terkawi, AS; Thomson, AJ; Thorne-Lyman, AL; Thrift, AG; Thurston, GD; Tobe-Gai, R; Tonelli, M; Topor-Madry, R; Topouzis, F; Tran, BX; Dimbuene, ZT; Tsilimbaris, M; Tura, AK; Tuzcu, EM; Tyrovolas, S; Ukwaja, KN; Undurraga, EA; Uneke, CJ; Uthman, OA; van Gool, CH; Varakin, YY; Vasankari, T; Venketasubramanian, N; Verma, RK; Violante, FS; Vladimirov, SK; Vlassov, VV; Vollset, SE; Wagner, GR; Waller, SG; Wang, LH; Watkins, DA; Weichenthal, S; Weiderpass, E; Weintraub, RG; Werdecker, A; Westerman, R; White, RA; Williams, HC; Wiysonge, CS; Wolfe, CDA; Won, S; Woodbrook, R; Wubshet, M; Xavier, D; Xu, GL; Yadav, AK; Yan, LJL; Yano, YCR; Yaseri, M; Ye, PP; Yebyo, HG; Yip, P; Yonemoto, N; Yoon, SJ; Younis, MZ; Yu, C; Zaidi, Z; Zaki, MES; Zeeb, H; Zhou, MG; Zodpey, S; Zuhlke, LJ; Murray, CJLBackground Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at the global, regional, and national scale over the period of 1990 to 2015. Methods We estimated incidence and prevalence by age, sex, cause, year, and geography with a wide range of updated and standardised analytical procedures. Improvements from GBD 2013 included the addition of new data sources, updates to literature reviews for 85 causes, and the identification and inclusion of additional studies published up to November, 2015, to expand the database used for estimation of non-fatal outcomes to 60 900 unique data sources. Prevalence and incidence by cause and sequelae were determined with DisMod-MR 2.1, an improved version of the DisMod-MR Bayesian meta-regression tool first developed for GBD 2010 and GBD 2013. For some causes, we used alternative modelling strategies where the complexity of the disease was not suited to DisMod-MR 2.1 or where incidence and prevalence needed to be determined from other data. For GBD 2015 we created a summary indicator that combines measures of income per capita, educational attainment, and fertility (the Socio-demographic Index [SDI]) and used it to compare observed patterns of health loss to the expected pattern for countries or locations with similar SDI scores. Findings We generated 9.3 billion estimates from the various combinations of prevalence, incidence, and YLDs for causes, sequelae, and impairments by age, sex, geography, and year. In 2015, two causes had acute incidences in excess of 1 billion: upper respiratory infections (17.2 billion, 95% uncertainty interval [UI] 15.4-19.2 billion) and diarrhoeal diseases (2.39 billion, 2.30-2.50 billion). Eight causes of chronic disease and injury each affected more than 10% of the world's population in 2015: permanent caries, tension-type headache, iron-deficiency anaemia, age-related and other hearing loss, migraine, genital herpes, refraction and accommodation disorders, and ascariasis. The impairment that affected the greatest number of people in 2015 was anaemia, with 2.36 billion (2.35-2.37 billion) individuals affected. The second and third leading impairments by number of individuals affected were hearing loss and vision loss, respectively. Between 2005 and 2015, there was little change in the leading causes of years lived with disability (YLDs) on a global basis. NCDs accounted for 18 of the leading 20 causes of age-standardised YLDs on a global scale. Where rates were decreasing, the rate of decrease for YLDs was slower than that of years of life lost (YLLs) for nearly every cause included in our analysis. For low SDI geographies, Group 1 causes typically accounted for 20-30% of total disability, largely attributable to nutritional deficiencies, malaria, neglected tropical diseases, HIV/AIDS, and tuberculosis. Lower back and neck pain was the leading global cause of disability in 2015 in most countries. The leading cause was sense organ disorders in 22 countries in Asia and Africa and one in central Latin America; diabetes in four countries in Oceania; HIV/AIDS in three southern sub-Saharan African countries; collective violence and legal intervention in two north African and Middle Eastern countries; iron-deficiency anaemia in Somalia and Venezuela; depression in Uganda; onchoceriasis in Liberia; and other neglected tropical diseases in the Democratic Republic of the Congo. Interpretation Ageing of the world's population is increasing the number of people living with sequelae of diseases and injuries. Shifts in the epidemiological profile driven by socioeconomic change also contribute to the continued increase in years lived with disability (YLDs) as well as the rate of increase in YLDs. Despite limitations imposed by gaps in data availability and the variable quality of the data available, the standardised and comprehensive approach of the GBD study provides opportunities to examine broad trends, compare those trends between countries or subnational geographies, benchmark against locations at similar stages of development, and gauge the strength or weakness of the estimates available. Copyright (C) The Author(s). Published by Elsevier Ltd.Item Protocol for development of a risk assessment tool for planning and management of religious mass-gathering events of India-a health system-strengthening initiative(Pilot and Feasibility Studies, 2019-06) Sharma, U; Desikachari, BR; Sarma, SBackground Religious mass gatherings (MGs) have always been an integral part of our society. At the outset, mass-gathering events provide challenging settings to plan a suitable emergency public health response. Published studies basically talk about retrospective reviews, case studies of the public health preparedness, or health care provided at individual events. Developing an understanding of the variables associated with MGs is the first step for public health managers. Risk assessment (RA) is a crucial part of pre-event planning as it helps foresee potential risks. Based on RA, one can develop preventive measures and ensure that the infrastructure to control the potential problems is in place. This study is an attempt to systemize RA process during MG events in a country that is culturally rich but with poor resources to handle such events. A RA tool will be developed for planning and management of religious MG events of India. Methods/design Various strategies will be used to develop the risk assessment tool (RA tool). Extensive review of literature clubbed with key informant interviews will be done in order to identify the risk variables and decide the domains and items of the tool. Further, this tool will be developed as a mobile-based application. The feasibility of the mobile-based RA tool will be tested in real-time MG event in one part of the country. Concurrently in the same event, a community survey of residents and visitors will be done in order to assess public perceptions of public health and environmental risks associated with MG events. Discussion The findings of this study will provide insights into the public health and environmental concerns that need to be considered if preventive strategies and intervention programs are to be designed for MG events. A “RA Tool,” which can be used in the planning and management of MG events by the public health managers will strengthen the existing health systems preparedness plans for MGs.